Article
Insulin-like growth factor-1 (IGF-1), insulin-like growth factor-binding protein-3…
medRxiv · 2019 · Murphy, N.; Knuppel, A.; Papadimitriou, N.; Martin, R.; Tsilidis, K. K.; Smith-Byrne, K.; Fenson, G.; Perez-Cornago, A.; Travis, R. C.; Key, T. J.; Gunter, M. J.
Key facts
| Title | Insulin-like growth factor-1 (IGF-1), insulin-like growth factor-binding protein-3 (IGFBP-3) and breast cancer risk: observational and Mendelian randomization analyses |
|---|---|
| First author | Murphy, N.; Knuppel, A.; Papadimitriou, N.; Martin, R.; Tsilidis, K. K.; Smith-Byrne, K.; Fenson, G.; Perez-Cornago, A.; Travis, R. C.; Key, T. J.; Gunter, M. J. |
| Journal | medRxiv |
| Published | Oct 24, 2019 |
| DOI | 10.1101/809046 |
| Devices mentioned | K013842, K051564, K120199, K954537 |
| Product codes mentioned | DCN, JIT, JJE, JJF, JPK, LCP, NQD, PPM |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1